|
|
|
Constellium Se (NYSE: CSTM) |
|
|
|
| |
Constellium Se Income Statement Quarterly
CSTM
|
Select the Financial Report: |
Period: |
|
|
|
INCOME STATEMENT
(Quarterly GAAP In millions $) |
(Dec 31 2024)
Q4 2024 |
(Dec 31 2023)
Q4 2023 |
0
Q3 2023 |
0
Q2 2023 |
0
Q1 2023 |
| Revenue From Contract With Customer Excluding Assessed Tax |
|
|
- |
- |
- |
| Revenue |
|
|
- |
- |
- |
| Cost Of Sales |
|
|
- |
- |
- |
| Other Revenue |
|
|
- |
- |
- |
| Total Revenue |
7,335.00 |
8,107.20 |
0.00 |
0.00 |
0.00 |
| Cost Of Goods And Service Excluding DepreciationDepletion AndAmortization |
6,397.00 |
7,312.48 |
- |
- |
- |
| Gross
Profit |
938.00 |
795.20 |
0.00 |
0.00 |
0.00 |
| Selling, Administration, Marketing |
313.00 |
338.24 |
- |
- |
- |
| Depriciation & Amortization |
304.00 |
- |
- |
- |
- |
| Research and Development Expense |
49.00 |
58.24 |
- |
- |
- |
| Restructuring, Accretion & impairment charges |
- |
- |
- |
- |
- |
| Other operatinig exp. /-income |
26.00 |
-0.48 |
- |
- |
- |
| Unusual Expense /-Income |
- |
- |
- |
- |
- |
| Total operating costs including COS |
7,089.00 |
7,729.76 |
- |
- |
- |
| Operating income/-loss
|
246.00 |
377.44 |
- |
- |
- |
|
Other Deductions / - Income |
| Interest expense |
- |
- |
- |
- |
- |
| Interest income |
-111.00 |
- |
- |
- |
- |
| Net interest expense/-income |
-111.00 |
- |
- |
- |
- |
| Loss/ -Gain on Investment |
- |
- |
- |
- |
- |
| Foreign Currency Transaction (Gain) Loss |
- |
- |
- |
- |
- |
| Allowances, Health Care Trust Fund And Other |
- |
- |
- |
- |
- |
| Unexpected (Gain) Loss |
- |
- |
- |
- |
- |
| Other loss/ -income |
222.00 |
157.92 |
- |
- |
- |
| Total costs & expenses |
7,200.00 |
7,887.68 |
0.00 |
0.00 |
0.00 |
| Income /-loss before income taxes |
135.00 |
219.52 |
0.00 |
0.00 |
0.00 |
| Income taxes expenses/-benefit |
75.00 |
75.04 |
- |
- |
- |
| Income after income taxes |
60.00 |
144.48 |
0.00 |
0.00 |
0.00 |
| Net income/-loss
of other equity |
- |
0.00 |
- |
- |
- |
| Income/-loss
from cont. Ops. |
60.00 |
144.48 |
0.00 |
0.00 |
0.00 |
| Accounting change |
- |
- |
- |
- |
- |
| Discontinued operations |
- |
- |
- |
- |
- |
| Extraordinary items |
- |
- |
- |
- |
- |
| Net Income/-loss |
60.00 |
144.48 |
0.00 |
0.00 |
0.00 |
| Non-controlling interests |
4.00 |
4.48 |
- |
- |
- |
| Preferred dividends |
- |
- |
- |
- |
- |
| Other |
- |
- |
- |
- |
- |
| Income/-loss to shareholder |
56.00 |
140.00 |
0.00 |
0.00 |
0.00 |
| EBIT |
24.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBITD |
328.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBITDA |
328.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Per
Share (GAAP Quarterly, in $) |
(Dec 31 2024)
Q4 2024 |
(Dec 31 2023)
Q4 2023 |
0
Q3 2023 |
0
Q2 2023 |
0
Q1 2023 |
| Basic EPS (excl. extra
items) |
0.38 |
0.95 |
0.00 |
0.00 |
0.00 |
| Extraordinary items |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Basic Net EPS |
0.38 |
0.94 |
0.00 |
0.00 |
0.00 |
| Basic shares outstanding (Mill.
of Units) |
147.37 |
146.13 |
0.00 |
0.00 |
0.00 |
| EPS other shares |
- |
- |
- |
- |
- |
| Diluted Net EPS |
0.38 |
0.94 |
0.00 |
0.00 |
0.00 |
| Diluted average shares (Mill.
of Units) |
147.37 |
149.24 |
149.24 |
149.24 |
149.24 |
| Dividend per share |
- |
- |
- |
- |
- |
|
|
